Lincoln

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• High blood pressure1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Alnylam Pharmaceuticals1 trial
• Olema Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT06016738· Phase 3· Olema Pharmaceuticals, Inc.· Source

Closed trials

• Completed

  Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

  NCT06272487· Phase 2· Alnylam Pharmaceuticals· Source